Background illustration for clinical trials search

Paid Clinical Trials Riverside

Discover 3,005 paid clinical trials in Riverside, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

Gene Correction in Autologous CD34+ Hematopoietic Stem Cells (HbS to HbA) to Treat Severe Sickle Cell Disease

for
Sickle Cell Disease
Location: Los Angeles CA, Palo Alto CA, St Louis MO, Columbus OH,
Sponsor: Kamau Therapeutics

Sex: All

Age: 12 - 50

Code: NCT04819841

Phase 1, Phase 2, Recruiting
Active & Responsive

A Study Observing the Long-term, Effectiveness and Safety of Odevixibat (Bylvay) in Patients With Alagille Syndrome (ALGS) Who Are Receiving Ongoing Treatment

for
Alagille Syndrome
Location: Los Angeles CA, San Francisco CA, El Paso TX, Dallas TX,
Sponsor: Ipsen

Sex: All

Age: 0+

Code: NCT06850038

Recruiting
Active & Responsive

Very Brief Exposure: Development of a Novel Exposure Modality for Social Anxiety Disorder in Transition-Age Youth

for
Social Anxiety Disorder
Location: Los Angeles CA
Sponsor: Children's Hospital Los Angeles

Sex: All

Age: 16 - 22

Code: NCT06526260

Recruiting
Active & Responsive

Nephrotic Syndrome Study Network

for
Minimal Change Disease (MCD), Membranous Nephropathy,
Location: Los Angeles CA, Torrance CA, Palo Alto CA, Spokane WA,
Sponsor: University of Michigan

Sex: All

Age: 0 - 70+

Code: NCT01209000

Recruiting
Active & Responsive

ATSN-201 Gene Therapy in RS1-Associated X-linked Retinoschisis

for
X-linked Retinoschisis
Location: Los Angeles CA, Phoenix AZ, San Francisco CA,
Sponsor: Atsena Therapeutics Inc.

Sex: All

Age: 5+

Code: NCT05878860

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Study of Cabozantinib With Selumetinib for Plexiform Neurofibromas

for
Neurofibromatosis 1, Plexiform Neurofibroma
Location: Los Angeles CA, Dallas TX, Birmingham AL,
Sponsor: Girish Dhall, MD

Sex: All

Age: 16+

Code: NCT06502171

Phase 1, Recruiting
Active & Responsive

A Clinical Study of Letermovir (MK-8228) in Children and Adolescents Who Receive a Kidney Transplant (KT) (MK-8228-077)

for
Cytomegalovirus Prophylaxis
Location: Los Angeles CA, Palo Alto CA, San Francisco CA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 0 - 17

Code: NCT07199465

Phase 1, Recruiting
Active & Responsive

Fontan Udenafil Exercise Longitudinal Assessment Trial - 2

for
Single Ventricle Heart Disease
Location: Los Angeles CA, San Diego CA, Phoenix AZ,
Sponsor: Mezzion Pharma Co. Ltd

Sex: All

Age: 12 - 18

Code: NCT05918211

Phase 3, Recruiting
Active & Responsive

A Double Blind Study Performed to Evaluate the Efficacy and the Safety of EscharEx in Debridement of VLU (VALUE)

for
Venous Leg Ulcer (VLU)
Location: Los Angeles CA, Vista CA, Fresno CA, San Francisco CA,
Sponsor: MediWound Ltd

Sex: All

Age: 18+

Code: NCT06568627

Phase 3, Recruiting
Active & Responsive

Study of GS-0415 and How It Works in People With HIV

for
HIV -1 Infection
Location: Los Angeles CA, Las Vegas NV, Indianapolis IN,
Sponsor: Gilead Sciences

Sex: All

Age: 18 - 65

Code: NCT07719491

Phase 1, Recruiting
Active & Responsive

A Gaucher Disease Gene Therapy Trial With FLT201

for
Gaucher Disease Type 1
Location: Los Angeles CA, San Francisco CA, Aurora CO, Dallas TX,
Sponsor: Spur Therapeutics

Sex: All

Age: 18+

Code: NCT07223944

Phase 3, Recruiting
Active & Responsive

A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

for
Pulmonary Hypertension, Interstitial Lung Disease (ILD),
Location: Torrance CA, Santa Barbara CA, Albuquerque NM,
Sponsor: Pulmovant, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07333183

Phase 2, Recruiting
Active & Responsive

A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed

for
HIV Infections
Location: Los Angeles CA, West Hollywood CA, San Diego CA,
Sponsor: ViiV Healthcare

Sex: All

Age: 12+

Code: NCT07650916

Phase 3, Recruiting
Active & Responsive

A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)

for
Pulmonary Arterial Hypertension
Location: Los Angeles CA, Torrance CA, Santa Barbara CA, Omaha NE,
Sponsor: Insmed Incorporated

Sex: All

Age: 18 - 70+

Code: NCT07481981

Phase 3, Recruiting
Active & Responsive

A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)

for
Primary Immune Thrombocytopenia (ITP),
Location: Torrance CA, Salt Lake City UT, Billings MT,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07421167

Phase 2, Recruiting
Active & Responsive

Study of Oral MRT-2359 With Apalutamide in Prostate Cancer

for
Castration-Resistant Prostate Cancer (CRPC),
Location: Los Angeles CA, West Valley City UT, Seattle WA,
Sponsor: Monte Rosa Therapeutics, Inc

Sex: Male

Age: 18+

Code: NCT07745361

Phase 2, Recruiting
Active & Responsive

A Study in Patients With Metastatic Castration-Resistant Prostate Cancer

for
Metastatic Castration Resistant Prostate Cancer, mCRPC,
Location: Los Angeles CA, San Antonio TX, Fort Worth TX,
Sponsor: Flare Therapeutics Inc.

Sex: Male

Age: 18+

Code: NCT07719361

Phase 1, Recruiting
Active & Responsive

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer

for
Colorectal Cancer
Location: Los Angeles CA, West Valley City UT, Seattle WA,
Sponsor: Verastem, Inc.

Sex: All

Age: 18+

Code: NCT07659795

Phase 2, Recruiting
Active & Responsive

Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer

for
HR+ HER2- Breast Cancer
Location: Los Angeles CA, Springfield OR, Lone Tree CO,
Sponsor: Faeth Therapeutics

Sex: All

Age: 18+

Code: NCT07558733

Phase 1, Phase 2, Recruiting
Active & Responsive

Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease

for
Graves' Disease
Location: Torrance CA, La Mesa CA, Gilbert AZ, Tucson AZ,
Sponsor: Yarrow Bioscience, Inc.

Sex: All

Age: 18+

Code: NCT07682896

Phase 2, Recruiting